Validation of the Combined Biomarker for Prediction of Response to Checkpoint Inhibitor in Patients with Advanced Cancer

SIMPLE SUMMARY: IMAGiC model is the model consisting of four-gene and PD-L1 expression levels to predict immunotherapy response. The IMAGiC model’s predictive performance was validated in patients with several advanced tumor types in this study. The PFS and OS demonstrated significant differences be...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin-Chul, Heo, You-Jeong, Kang, So-Young, Lee, Jeeyun, Kim, Kyoung-Mee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151730/
https://www.ncbi.nlm.nih.gov/pubmed/34065963
http://dx.doi.org/10.3390/cancers13102316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151730/
https://www.ncbi.nlm.nih.gov/pubmed/34065963
http://dx.doi.org/10.3390/cancers13102316

Ejemplares similares